Welcome to the Prostate Cancer Center of Seattle

In 1985, Drs. Blasko and Grimm pioneered  modern prostate brachytherapy in the US. Along with their colleagues, they have treated over 10,000 patients and trained over 6,000 physicians, nurses and physicists  to perform seed implantation.  In 1997 , under their direction, along with Dr Sylvester, they established the Seattle Prostate Institute with a primary interest  in improving prostate Brachytherapy. In 2009, we established a new center,  the Prostate Cancer Center of Seattle,  as a premier center for  the diagnosis and treatment  of  primary and recurrent prostate cancer. Our center is dedicated to finding the the best prostate cancer treatment option for you.

In the News

Current PSA Screening Guidelines

Should I screen for prostate cancer? Prostate cancer (PC) is the second leading cause of cancer-related mortality in men, with approximately 28,000 deaths per year. Screening for PC with the prostate-specific antigen (PSA) test carries some controversy, and patient questions arise about whether to have a PSA test, when, and how to interpret the test results .

European Study: PSA Screening Reduces Mortality Up to 31%External Link

PSA screening has reduced prostate cancer mortality up to 31%, according to findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC).

Important  Info Regarding Radical Prostatectomy Surgery External Link

The most serious complications…appeared more often in men who underwent minimally invasive surgery.

Connected Seed Technology developed by PCCS physicians for Permanent Seed Implantation 

Connected seeds  either Thin Strands or Source Link by Bard are proving to result in improved dosimetry and side effects

Prostate Cancer Results Study Group updates Comparative Effectiveness of Prostate Cancer Treatments

Dr. Grimm, lead author, has published the report from the Prostate Cancer Results Study Group comparing treatment results for prostate cancer

Prostate Cancer Center of Seattle Physicians using Focal Therapies to Treat Recurrent Prostate Cancer 

Patients with Local Failure after Seed implantation or External Beam radiation have limited options. PCCS physicians are embarking on new diagnostic and therapeutic strategies to treat  this patients and preserve function.

Our Mission

PCCS strives to meet the highest standards of care for our patients through individual care, clinical research and the latest in advanced prostate cancer technology. We are dedicated to improving the quality of life and increasing better treatment outcomes in every patient we see. Please contact us to see how we can help you.